280 related articles for article (PubMed ID: 2843021)
1. Correlation of ovarian follicle size and the urinary excretion of oestrone glucuronide, luteinizing hormone and pregnanediol glucuronide in spontaneous cycles.
Adekunle AO; Collins WP; Whitehead MI
Afr J Med Med Sci; 1988 Jun; 17(2):77-82. PubMed ID: 2843021
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between indicators of the fertile period of the menstrual cycle and ultrasonically-determined ovulation].
Croce P; Quarenghi A; Montanari G; Barbato M; Pravettoni G; Bertolotti G
Minerva Endocrinol; 1989; 14(3):147-52. PubMed ID: 2622425
[TBL] [Abstract][Full Text] [Related]
4. A prospective multicentre study to develop universal immunochemical tests for predicting the fertile period in women. World Health Organisation Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
Int J Fertil; 1985; 30(3):18-30. PubMed ID: 2867054
[TBL] [Abstract][Full Text] [Related]
5. Determination of the time of ovulation in chimpanzees by measurement of LH, estrone sulfate, and pregnanediol 3 alpha-glucuronide in urine: comparison with serum hormone patterns.
Steinetz BG; Ducrot C; Randolph C; Mahoney CJ
J Med Primatol; 1992 Jul; 21(5):239-45. PubMed ID: 1404332
[TBL] [Abstract][Full Text] [Related]
6. Prediction of ovulation with the assessment of LH and the E1G/P2G ratio in urinary samples.
Baviera G; Carroccio G; Scurria L; Pizzi V; Scarselli G
Acta Eur Fertil; 1988; 19(3):139-42. PubMed ID: 3067480
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
8. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
[TBL] [Abstract][Full Text] [Related]
10. The effect of conception on the concentration of urinary oestrone-3-glucuronide, LH/hCG and pregnanediol-3 alpha-glucuronide.
Branch CM; Collins PO; Kilpatrick MJ; Collins WP
Acta Endocrinol (Copenh); 1980 Feb; 93(2):228-33. PubMed ID: 7376791
[TBL] [Abstract][Full Text] [Related]
11. Excretion of estrone-3-glucuronide in urine in spontaneous and induced ovulatory cycles.
Khatkhatay MI; Sankolli GM; Meherji PK; Chowdhury V; Joshi UM
Int J Fertil; 1988; 33(3):181-7. PubMed ID: 2899564
[TBL] [Abstract][Full Text] [Related]
12. Relationship between sleep and secretion of gonadotropin and ovarian hormones in women with normal cycles.
Touzet S; Rabilloud M; Boehringer H; Barranco E; Ecochard R
Fertil Steril; 2002 Apr; 77(4):738-44. PubMed ID: 11937126
[TBL] [Abstract][Full Text] [Related]
13. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
Roos J; Johnson S; Weddell S; Godehardt E; Schiffner J; Freundl G; Gnoth C
Eur J Contracept Reprod Health Care; 2015; 20(6):438-50. PubMed ID: 26018113
[TBL] [Abstract][Full Text] [Related]
14. Determination of ovarian function using first morning urine steroid assays.
Denari JH; Farinati Z; Casas PR; Oliva A
Obstet Gynecol; 1981 Jul; 58(1):5-9. PubMed ID: 7195531
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the urinary luteinizing hormone surge in young ovulatory women.
Park SJ; Goldsmith LT; Skurnick JH; Wojtczuk A; Weiss G
Fertil Steril; 2007 Sep; 88(3):684-90. PubMed ID: 17434509
[TBL] [Abstract][Full Text] [Related]
16. Monitoring the menstrual cycle of humans and lowland gorillas based on urinary profiles of bioactive follicle-stimulating hormone and steroid metabolites.
Dahl KD; Czekala NM; Lim P; Hsueh AJ
J Clin Endocrinol Metab; 1987 Mar; 64(3):486-93. PubMed ID: 3102537
[TBL] [Abstract][Full Text] [Related]
17. Mean versus individual hormonal profiles in the menstrual cycle.
Alliende ME
Fertil Steril; 2002 Jul; 78(1):90-5. PubMed ID: 12095496
[TBL] [Abstract][Full Text] [Related]
18. Validation of the dual analyte assay of the oestrone:pregnanediol ratio in monitoring ovarian function.
Fabres C; Zegers-Hochschild F; Altieri E; Llados C
Hum Reprod; 1993 Feb; 8(2):208-10. PubMed ID: 8473420
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of subtle and severe menstrual disturbances in exercising women: confirmation using daily hormone measures.
De Souza MJ; Toombs RJ; Scheid JL; O'Donnell E; West SL; Williams NI
Hum Reprod; 2010 Feb; 25(2):491-503. PubMed ID: 19945961
[TBL] [Abstract][Full Text] [Related]
20. Urinary progesterone and pregnanediol. Use for monitoring progesterone treatment.
Stanczyk FZ; Gentzschein E; Ary BA; Kojima T; Ziogas A; Lobo RA
J Reprod Med; 1997 Apr; 42(4):216-22. PubMed ID: 9131494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
